N Engl J Med. 2004 Apr 1;350(14):1461-3.

Shedding light on immunotherapy for cancer.

Rosenberg SA.

Source

National Cancer Institute, Bethesda, Md, USA.

PMID:: 15070799; [PubMed - indexed for MEDLINE]
PMCID: PMC2275326

Free PMC Article

Images from this publication.See all images (1) Free text

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

Priming of naive T cells inside tumors leads to eradication of established tumors. [Nat Immunol. 2004]
Priming of naive T cells inside tumors leads to eradication of established tumors.
Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Nat Immunol. 2004 Feb; 5(2):141-9. Epub 2004 Jan 4.
LIGHTing the way for tumor immunity. [Nat Immunol. 2004]
LIGHTing the way for tumor immunity.
Houghton AN. Nat Immunol. 2004 Feb; 5(2):123-4.
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. [J Immunol. 2001]
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity.
Morel Y, Truneh A, Sweet RW, Olive D, Costello RT. J Immunol. 2001 Sep 1; 167(5):2479-86.
Review LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. [Cytokine Growth Factor Rev. 2003]
Review LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.
Granger SW, Rickert S. Cytokine Growth Factor Rev. 2003 Jun-Aug; 14(3-4):289-96.
Review The role of LIGHT in T cell-mediated immunity. [Immunol Res. 2004]
Review The role of LIGHT in T cell-mediated immunity.
Wang J, Fu YX. Immunol Res. 2004; 30(2):201-14.

See reviews... See all...

Cited by 22 PubMed Central articles

Review NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies. [Biol Blood Marrow Transplant. 2010]
Review NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.
Alyea EP, DeAngelo DJ, Moldrem J, Pagel JM, Przepiorka D, Sadelin M, Young JW, Giralt S, Bishop M, Riddell S. Biol Blood Marrow Transplant. 2010 Aug; 16(8):1037-69. Epub 2010 May 24.
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. [J Immunol. 2010]
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T. J Immunol. 2010 Jun 1; 184(11):6529-36. Epub 2010 Apr 26.
Modulation of T-cell activation by malignant melanoma initiating cells. [Cancer Res. 2010]
Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T, Schütte U, Frank NY, Zhan Q, Hoerning A, Robles SC, Zhou J, Hodi FS, Spagnoli GC, Murphy GF, et al. Cancer Res. 2010 Jan 15; 70(2):697-708. Epub 2010 Jan 12.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Shedding light on immunotherapy for cancer.
Shedding light on immunotherapy for cancer.
N Engl J Med. 2004 Apr 1 ;350(14):1461-3.

PubMed
What does it mean to be a physician?
What does it mean to be a physician?
Acad Med. 2005 Dec ;80(12):1077-8.

PubMed
Ghost story: at medical journals, writers paid by industry play big role.
Ghost story: at medical journals, writers paid by industry play big role.
Wall St J (East Ed). 2005 Dec 13 :A1, A8.

PubMed
BAK1 gene variation and abdominal aortic aneurysms.
BAK1 gene variation and abdominal aortic aneurysms.
Hum Mutat. 2009 Jul ;30(7):1043-7.

PubMed
Identification of cis-acting sites for condensin loading onto budding yeast chro...
Identification of cis-acting sites for condensin loading onto budding yeast chromosomes.
Genes Dev. 2008 Aug 15 ;22(16):2215-27.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Shedding light on immunotherapy for cancer.

Source

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Cited by 22 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information